#$%^&*AU2018200270A120180201.pdf#####Abstract The invention provides methods and compositions to detect expression of one or more biomarkers for identifying and treating patients who are likely to be responsive to VEGF 5 antagonist therapy. The invention also provides kits and articles of manufacture for use in the methods. 9860294_1 (GHMatters) P97576.AU.1